139 related articles for article (PubMed ID: 14597212)
1. B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro.
Stewart DM; McAvoy MJ; Hilbert DM; Nelson DL
Clin Immunol; 2003 Nov; 109(2):137-43. PubMed ID: 14597212
[TBL] [Abstract][Full Text] [Related]
2. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.
Moore PA; Belvedere O; Orr A; Pieri K; LaFleur DW; Feng P; Soppet D; Charters M; Gentz R; Parmelee D; Li Y; Galperina O; Giri J; Roschke V; Nardelli B; Carrell J; Sosnovtseva S; Greenfield W; Ruben SM; Olsen HS; Fikes J; Hilbert DM
Science; 1999 Jul; 285(5425):260-3. PubMed ID: 10398604
[TBL] [Abstract][Full Text] [Related]
3. B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases.
Nardelli B; Moore PA; Li Y; Hilbert DM
Leuk Lymphoma; 2002 Jul; 43(7):1367-73. PubMed ID: 12389615
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and release of B-lymphocyte stimulator from myeloid cells.
Nardelli B; Belvedere O; Roschke V; Moore PA; Olsen HS; Migone TS; Sosnovtseva S; Carrell JA; Feng P; Giri JG; Hilbert DM
Blood; 2001 Jan; 97(1):198-204. PubMed ID: 11133761
[TBL] [Abstract][Full Text] [Related]
5. [The immunopotentiation of human B lymphocyte stimulator C-terminal peptide].
Tian RY; Han W; Yu Y; Chen Y; Yu GS; Yang SL; Gong Y
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1128-32. PubMed ID: 14673506
[TBL] [Abstract][Full Text] [Related]
6. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma.
Briones J; Timmerman JM; Hilbert DM; Levy R
Exp Hematol; 2002 Feb; 30(2):135-41. PubMed ID: 11823048
[TBL] [Abstract][Full Text] [Related]
7. To B or not to B: TNF family signaling in lymphocytes.
Siegel RM; Lenardo MJ
Nat Immunol; 2001 Jul; 2(7):577-8. PubMed ID: 11429537
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (BLyS) in mice.
Parry TJ; Riccobene TA; Strawn SJ; Williams R; Daoud R; Carrell J; Sosnovtseva S; Miceli RC; Poortman CM; Sekut L; Li Y; Fikes J; Sung C
J Pharmacol Exp Ther; 2001 Feb; 296(2):396-404. PubMed ID: 11160623
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of human BLyS in patients with common variable immunodeficiency.
Losi CG; Salzer U; Gatta R; Lougaris V; Cattaneo G; Meini A; Soresina A; Grimbacher B; Plebani A
J Clin Immunol; 2006 Jul; 26(4):396-9. PubMed ID: 16838132
[TBL] [Abstract][Full Text] [Related]
10. Construction and direct immunization of eukaryotic expression plasmid encoding human soluble B lymphocyte stimulator.
Chen G; Du H; Peng S; Xu D; Wang J
Front Biosci; 2006 Jan; 11():121-5. PubMed ID: 16146718
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of BLyS action in B cell immunity.
Do RK; Chen-Kiang S
Cytokine Growth Factor Rev; 2002 Feb; 13(1):19-25. PubMed ID: 11750877
[TBL] [Abstract][Full Text] [Related]
12. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity.
Yan M; Marsters SA; Grewal IS; Wang H; Ashkenazi A; Dixit VM
Nat Immunol; 2000 Jul; 1(1):37-41. PubMed ID: 10881172
[TBL] [Abstract][Full Text] [Related]
13. B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.
Elsawa SF; Novak AJ; Grote DM; Ziesmer SC; Witzig TE; Kyle RA; Dillon SR; Harder B; Gross JA; Ansell SM
Blood; 2006 Apr; 107(7):2882-8. PubMed ID: 16304043
[TBL] [Abstract][Full Text] [Related]
14. Construction and function of two Cys146-mutants with high activity, derived from recombinant human soluble B lymphocyte stimulator.
Chen G; Peng S; Zou M; Xu H; Xu D; Wang J
J Biochem; 2004 Jul; 136(1):73-9. PubMed ID: 15269242
[TBL] [Abstract][Full Text] [Related]
15. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
16. A role for BLyS in the activation of innate immune cells.
Chang SK; Arendt BK; Darce JR; Wu X; Jelinek DF
Blood; 2006 Oct; 108(8):2687-94. PubMed ID: 16825497
[TBL] [Abstract][Full Text] [Related]
17. Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.
Jelinek DF; Darce JR
Curr Dir Autoimmun; 2005; 8():266-88. PubMed ID: 15564725
[TBL] [Abstract][Full Text] [Related]
18. B lymphocyte stimulator activates p38 mitogen-activated protein kinase in human Ig class switch recombination.
Yamada T; Zhang K; Yamada A; Zhu D; Saxon A
Am J Respir Cell Mol Biol; 2005 May; 32(5):388-94. PubMed ID: 15668322
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR
Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.
Do RK; Hatada E; Lee H; Tourigny MR; Hilbert D; Chen-Kiang S
J Exp Med; 2000 Oct; 192(7):953-64. PubMed ID: 11015437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
